1 false false false false false false false false false false true false false false false false false No description of principal activity 2024-01-01 Sage Accounts Production Advanced 2023 - FRS102_2023 xbrli:pure xbrli:shares iso4217:GBP 11622667 2024-01-01 2024-12-31 11622667 2024-12-31 11622667 2023-12-31 11622667 2023-01-01 2023-12-31 11622667 2023-12-31 11622667 2022-12-31 11622667 bus:OrdinaryShareClass1 2024-01-01 2024-12-31 11622667 bus:Director1 2024-01-01 2024-12-31 11622667 core:WithinOneYear 2024-12-31 11622667 core:WithinOneYear 2023-12-31 11622667 core:ShareCapital 2024-12-31 11622667 core:ShareCapital 2023-12-31 11622667 core:RetainedEarningsAccumulatedLosses 2024-12-31 11622667 core:RetainedEarningsAccumulatedLosses 2023-12-31 11622667 bus:SmallEntities 2024-01-01 2024-12-31 11622667 bus:AuditExempt-NoAccountantsReport 2024-01-01 2024-12-31 11622667 bus:SmallCompaniesRegimeForAccounts 2024-01-01 2024-12-31 11622667 bus:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 11622667 bus:FullAccounts 2024-01-01 2024-12-31 11622667 bus:OrdinaryShareClass1 2024-12-31 11622667 bus:OrdinaryShareClass1 2023-12-31
COMPANY REGISTRATION NUMBER: 11622667
ACTIV MEDICAL DISPOSABLES UK LTD
Filleted Unaudited Financial Statements
31 December 2024
ACTIV MEDICAL DISPOSABLES UK LTD
Statement of Financial Position
31 December 2024
2024
2023
Note
£
£
Current assets
Debtors
5
10,722
11,030
Creditors: amounts falling due within one year
6
189,603
185,069
---------
---------
Net current liabilities
178,881
174,039
---------
---------
Total assets less current liabilities
( 178,881)
( 174,039)
---------
---------
Net liabilities
( 178,881)
( 174,039)
---------
---------
Capital and reserves
Called up share capital
8
10,000
10,000
Profit and loss account
( 188,881)
( 184,039)
---------
---------
Shareholders deficit
( 178,881)
( 174,039)
---------
---------
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.
For the year ending 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements were approved by the board of directors and authorised for issue on 13 March 2025 , and are signed on behalf of the board by:
MR. F REQUIER
Director
Company registration number: 11622667
ACTIV MEDICAL DISPOSABLES UK LTD
Notes to the Financial Statements
Year ended 31 December 2024
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Wilberforce House, Station Road, London, NW4 4QE.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Disclosure exemptions
The entity satisfies the criteria of being a qualifying entity as defined in FRS 102 Section 1A. As such, advantage has been taken of the following disclosure exemptions available under paragraph 1.12 of FRS 102: (a) Disclosures in respect of each class of share capital have not been presented. (b) No cash flow statement has been presented for the company. (c) Disclosures in respect of financial instruments have not been presented. (d) Disclosures in respect of share-based payments have not been presented. (e) No disclosure has been given for the aggregate remuneration of key management personnel.
4. Employee numbers
The average number of persons employed by the company during the year amounted to 1 (2023: 1 ).
5. Debtors
2024
2023
£
£
Other debtors
10,722
11,030
--------
--------
6. Creditors: amounts falling due within one year
2024
2023
£
£
Trade creditors
14,824
14,422
Amounts owed to group undertakings and undertakings in which the company has a participating interest
173,829
170,647
Other creditors
950
---------
---------
189,603
185,069
---------
---------
7. Financial instruments
Where reduced disclosures are applied, disclosures from the Companies Act 2006 still need to be made regarding the fair value of the instruments in each category and the changes in value recognised in profit and loss. Disclosures of the significant assumptions underlying the valuation models and techniques used, and extent and nature of derivative instruments are also required.
8. Called up share capital
Issued, called up and fully paid
2024
2023
No.
£
No.
£
Ordinary shares of £ 1 each
10,000
10,000
10,000
10,000
--------
--------
--------
--------